Taro Pharms North Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO PHARMS NORTH, and what generic and branded alternatives to TARO PHARMS NORTH drugs are available?
TARO PHARMS NORTH has one approved drug.
Summary for Taro Pharms North
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Taro Pharms North
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms North | PSORCON | diflorasone diacetate | CREAM;TOPICAL | 020205-001 | Nov 20, 1992 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
